title: [Outpatient treatment of pelvic ureteral calculi with extracorporeal lithotripsy. Report of a series of 200 patients consecutively treated].
abstract: OBJECTIVE
  To demonstrate the feasibility of first-line outpatient treatment of symptomatic stones of the pelvic ureter (sometimes immediately following an episode of renal colic), without anaesthesia, by extracorporeal shock-wave lithotripsy using a latest generation apparatus (EDAP LT02) with concomitant dual guidance.
  
  
  METHODS
  The mean age of the patients was 45 years. The mean stone diameter was 7 mm (range: 3 to 25 mm). Lithotripsy was performed under dual ultrasound and fluoroscopic guidance. All patients were reviewed at 3 months with follow-up and x-rays.
  
  
  RESULTS
  Fragmentation was considered to be complete in 79% of cases, partial in 10.5% of cases and absent in 10.5% of cases. Overall, 87% of stones were completely eliminated at 3 months. The only complication was fever of 38.5 degrees C requiring urinary tract drainage and subsequent ureteroscopy. Complementary treatment was necessary in 26 cases: ureteroscopy (n = 20), alkalinization (n = 1), Dornier ESWL (n = 5).
  
  
  CONCLUSIONS
  ESWL by EDAP LT02 allows first-line outpatient treatment of stones of the pelvic ureter with a satisfactory success rate.
authors.affiliation: Service d'Urologie, Hôpital Tenon, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Tligui
authors.forename: M
authors.initials: M
authors.lastname: Nouri
authors.forename: K
authors.initials: K
authors.lastname: Tchala
authors.forename: F
authors.initials: F
authors.lastname: Haab
authors.forename: B
authors.initials: B
authors.lastname: Gattegno
authors.forename: P
authors.initials: P
authors.lastname: Thibault
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D003663:Decision Trees; D005240:Feasibility Studies; D006801:Humans; D007682:Kidney Pelvis; D008096:Lithotripsy; D008875:Middle Aged; D011446:Prospective Studies; D014514:Ureteral Calculi / Q000628:therapy*